Skip to main content
. 2024 Sep 10;24:311. doi: 10.1186/s12935-024-03496-x

Fig. 2.

Fig. 2

Prognostic association of immune cell subsets in the pan-cancer setting. (A&B) Unadjusted HRs and 95% CI limited to patients with CIBERSORT p-value < 0.05. (C) HRs and 95% CI adjusted for clinicopathological features. CI, confidence interval; DFS, disease-free survival; HR, hazard ratio; OS, overall survival; *, p < 0.05